HansaBioMed Life Sciences

Fluorescent Bead Standards Enable Standardized EV Analysis and Quantitative Marker Measurement

Next-level fluorescent analysis with our FLuoQuant Beads available in multiple levels of fluorescence.

Danilo Mladenović, Tayfun Tatar, Paolo Guazzi (HansaBioMed Life Sciences, Tallinn, Estonia)
Fluorescent Bead Standards Enable Standardized EV Analysis and Quantitative Marker Measurement

 

Introduction

 

Quantification of extracellular vesicle (EV) markers by single-particle analyzers is limited by the lack of suitable fluorescence calibration standards. Conventional flow cytometry beads are typically too bright, too large, and too dilute for platforms such as nanoparticle tracking analysis (NTA).


Here, we present HansaBioMed’s fluorescent bead standards designed for EV-scale measurements, enabling conversion of arbitrary fluorescence units into quantitative FITC ERF values. We further demonstrate their application for EV marker quantification and highlight the superior brightness of HansaBioMed’s FluoEVs compared to antibody-labelled EVs.

 

Figure 1: Representation of fluorescent beads by HBM

 

Materials and Methods

 

HansaBioMed fluorescent bead standards were calibrated using a NIST-traceable FITC reference to assign FITC ERF values (Table 1) and used to standardize fluorescence measurements on the Particle Metrix ZetaView Evolution.


COLO-derived EVs were labelled with Alexa Fluor 488-conjugated anti-CD63 antibody and analyzed by NTA in fluorescence mode. FluoEVs expressing EGFP-CD63 were measured under identical settings for comparison.

 

HBM Fluorescent BeadsERF Values (NIST-traceable FITC)
P13958
P2534
P3204
P456

Table 1: ERF values for different fluorescent bead options

 

Results

 

HBM fluorescent bead standards were successfully implemented on ZetaView Evolution (Figure 2). Their high particle concentration (up to 10^12 particles/mL), appropriate size range (50-200 nm), and fluorescence intensity (50-4000 FITC ERF values).

 

Figure 2: HBM fluorescent bead standards measured with ZetaView Evolution demonstrate high linearity of fluorescence intensity across the ERF range, as well as suitable concentration and size range for EV applications.

 

Following calibration, standardized fluorescence measurements enabled quantification of marker abundance at the single EV level. COLO-derived EVs labelled with anti-CD63-Alexa Fluor 488 exhibited a median fluorescence intensity of approximately 20 FITC ERF (Figure 3). In contrast, FluoEVs expressing EGFP-CD63 showed substantially higher fluorescence, with a median value of approximately 160 FITC ERF under identical measurement conditions.

 

Figure 3. Representative fluorescence dot plots of COLO EVs labelled with anti-CD63-Alexa Fluor 488 and FluoEVs EGFP-CD63, including median fluorescence intensities expressed in FITC ERF units.

 

Conclusion

 

  • HansaBioMed fluorescent bead standards provide a suitable combination of concentration (up to 10¹² particles/mL), size (50–200 nm), and fluorescence intensity for EV analysis on single-particle platforms.
    Calibration using NIST-traceable FITC ERF values enables conversion of arbitrary fluorescence units into quantitative, comparable measurements, with high linearity demonstrated on ZetaView Evolution.
    Standardized fluorescence analysis reveals that FluoEVs exhibit substantially higher brightness than antibody-labelled EVs, supporting their use as reliable and sensitive positive controls in EV detection assays.

Related Application Notes